Atlas Trials

Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG®

Clinical trial NCT06112834 · COMPLETED

Trial details

NCT number
NCT06112834
Sponsor
California Department of Public Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Botulism
Start date
2024-07-09
Primary completion
2025-06-02
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.